Study Shows Simeprevir Improves Hep C Therapy
Addition of simeprevir to peginterferon/ribavirin improves SVR rate among HCV patients
May 1, 2013
Simeprevir improves rates of sustained virologic response and may allow for a 24-week treatment duration when added to interferon-based therapy for chronic hepatitis C, according to data presented at the International Liver Congress in Amsterdam.
Continue reading this entire article:
http://www.healio.com/hepatology/chronic-hepatitis/news/online/%7B0BDBD39D-184B-496C-AFA9-7338569379F3%7D/Addition-of-simeprevir-to-peginterferonribavirin-improves-SVR-rate-among-HCV-patients